Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran

Pirmohamed M, Breckenridge A, Kitteringham N, Park BK. Adverse drug reactions. BMJ. 1998;316:1295–8.

Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277(4):301–6. doi: 10.1001/jama.277.4.301 .

Muehlberger N, Schneeweiss S, Hasford J. Adverse drug reaction monitoring-Cost and benefit considerations part I: frequency of adverse drug reactions causing hospital admissions. Pharmacoepidemiol Drug Saf. 1997;6(3):S71–7. doi:10.1002/(SICI)1099-1557(199710)6:3+<S71::AID-PDS282>3.3.CO;2-9.

Lazarou J, Pomeranz BH, Corey PH. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200–5. doi: 10.1001/jama.279.15.1200 .

Johnson JA, Bootman JL. Drug-related morbidity and mortality. a cost-of-illness model. Arch Intern Med. 1995;155:1949–56. doi: 10.1001/archinte.155.18.1949 .

Wiholm BE, Olsson S, Moore N, Wood S. Spontaneous reporting systems outside the United States. In: Strom BL, editor. Pharmacoepidemiology. Chichester: John Wiley & Sons Ltd; 1994. p. 139–55.

Ramezani Tehrani B, Javid Nikoo N. Report of the Iranian Pharmacovigilance Center. Razi J. 2007;12:85–90. Article in Persian.

Roberts PI, Wolfson DJ, Booth TG. The role of pharmacists in adverse drug reaction reporting. Drug Saf. 1994;11(1):7–11. doi: 10.2165/00002018-199411010-00002 .

Eland IA, Belton KJ, van Grootheest AC, Meiners AP, Rawlins MD, Stricker BHC. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol. 1999;48:623–7. doi: 10.1046/j.1365-2125.1999.00060.x .

Bateman DN, Sanders GLS, Rawling MD. Attitudes to adverse drug reaction reporting in the northern region. Br J Clin Pharmacol. 1992;34:421–6.

Belton K. The European Pharmacovigilance Research Group. attitude survey of adverse drug reaction reporting by healthcare professionals across the European Union. Eur J Clin Pharmacol. 1997;52:423–7. doi: 10.1007/s002280050314 .

Green CF, Mottram DR, et al. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol. 2001;51:81–6. doi: 10.1046/j.1365-2125.2001.01306.x .

Lee KK, Chan TY, Raymond K, Critchley JA. Pharmacists’ attitudes toward adverse drug reactions reporting in Hong Kong. Ann Pharmacother. 1994;28(12):1400–3.

Sweis D, Wong IC. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Saf. 2000;23(2):165–72. doi: 10.2165/00002018-200023020-00006 .

Generali JA, Danish MA, Rosenbaum SE. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists. Ann Pharmacother. 1995;29(4):365–9.

Herdeiro MT, Figueiras A, Polonia J, Gestal-Otero JJ. Influence of pharmacists’ attitudes on adverse drug reactions reporting: a case control study in Portugal. Drug Saf. 2006;29(4):331–40. doi: 10.2165/00002018-200629040-00004 .

Zerrin Toklu H, Uysal MK. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci. 2008;30(5):556–62. doi: 10.1007/s11096-008-9209-4 .

Granas AG, Buajordet M, Stenberg-Nilsen H, et al. Pharmacists’ attitudes toward the reporting of suspected adverse drug reactions in Norway. Pharmacoepidemiol Drug Saf. 2007;16:429–34. doi: 10.1002/pds.1298 .

Hasford J, Goettler K, et al. Physician’s knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol. 2002;55:945–50. doi: 10.1016/S0895-4356(02)00450-X .

Walker SR, Lumley CE. The attitudes of general practitioners to the monitoring and reporting of adverse drug reactions. Pharm Med. 1986;1:195–203.

Lumley CE, Walker SR, Hall GC, Staunton N, Grob PR. The under-reporting of adverse drug reactions seen in general practice. Pharm Med. 1986;1:205–12.

Belton KJ, Lewis SC, Payne S, Rawlins MD, Wood S. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol. 1995;39(3):223–6.

Cosentino M, Leoni O, et al. Attitudes to adverse drug reaction reporting by medical practitioners in a northern Italian district. Pharmacol Res. 1997;35(2):85–8. doi: 10.1006/phrs.1996.0138 .